๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rash conclusions from a phase 3 study of cetuximab?

โœ Scribed by Kevin J Harrington


Book ID
117785211
Publisher
The Lancet
Year
2010
Tongue
English
Weight
127 KB
Volume
11
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase 2 study of cetuximab in patients w
โœ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.